4//SEC Filing
Brister Mark 4
Accession 0001214659-19-006670
CIK 0001427570other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 4:40 PM ET
Size
5.5 KB
Accession
0001214659-19-006670
Insider Transaction Report
Form 4
Brister Mark
VP of Research and Development
Transactions
- Award
Stock Option (Right to Buy)
2019-10-25+13,000→ 13,000 totalExercise: $1.75Exp: 2029-10-25→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date.
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001323223
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 4:40 PM ET
- Size
- 5.5 KB